Maux de tête & Migraine
Natural health product licensed in Canada
- Licence holder
- Homeocan Inc.
- NPN or DIN-HM
- 80003301
- Status
- Active licence
- Licence date
- 4 May 2007
- Revision date
- 24 November 2011
- Form
- Granules
- Route of administration
- Orale
- Application type
- Homéopathique
If this product were sold in France
- Information
Homeopathic medicine in Canada, outside the scope of food supplements in France. Nutrient doses are not analysed.
Homéopathique. Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cyclamen europaeum Source : Tubercule | 4 D | Not calculated |
| Melilotus officinalis Source : Parties aériennes | 4 D | Not calculated |
| Lycopodium clavatum Source : Spores | 5 D | Not calculated |
| Digitalis purpurea Source : Feuille | 9 D | Not calculated |
| Glonoïnum Source : Chimique | 6 D | Not calculated |
| Antimonium crudum Source : Chimique | 9 D | Not calculated |
Non-medicinal ingredients
Lactose, Saccharose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years ; maximum: 12 years | 2 granule | 3 Tous les jours |
| Adultes | minimum: 12 years | 3 granule | 3 Tous les jours |
Uses authorised in Canada
Médicament homéopathique pour aider à soulager les symptômes associés aux maux de tête et aux migraines.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ne pas utiliser si le sceau de sécurité est brisé. Garder hors de la portée des enfants. Ne pas administrer aux bébés de 0 à 2 ans. Consulter un praticien de la santé avant l'usage si vous êtes enceinte ou si vous allaitez. Consulter un praticien de la santé si les symptômes persistent ou s'aggravent après 72 heures. Ne pas dépasser la posologie recommandée.
Source
Official Health Canada record, licence 80003301
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2011. Photograph the packaging to check whether it has changed. Photograph the packaging